TNFRSF11B and cardiovascular disorder: In this context, an increasing body of evidence indicates that signaling through the RANK (receptor activator of nuclear factor κB)/RANKL (RANK ligand)/OPG (osteoprotegerin) axis might be involved in the pathophysiology of cardiovascular diseases.